Curaleaf Holdings (CURLF) Capital Expenditures (QoQ) (2020 - 2024)
Curaleaf Holdings (CURLF) Capital Expenditures (QoQ) (2020 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 390.53% |
| Dec 31, 2023 | 436.22% |
| Jun 30, 2022 | -1.15% |
| Mar 31, 2022 | 45.13% |
| Dec 31, 2021 | -24.02% |
| Sep 30, 2021 | -5.01% |
| Jun 30, 2021 | -33.39% |
| Mar 31, 2021 | -115.99% |
| Dec 31, 2020 | 1,151.53% |
| Sep 30, 2020 | 35.18% |
| Jun 30, 2020 | -27.05% |
| Mar 31, 2020 | -115.23% |